Steven Cohen's ALDX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 94,094 shares of Aldeyra Therapeutics, Inc. (ALDX) worth $487,407, representing 0.00% of the portfolio. First purchased in 2019-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ALDX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2020, adding 641,918 shares. Largest reduction occurred in Q1 2021, reducing 858,270 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Aldeyra Therapeutics (ALDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aldeyra Therapeutics (ALDX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +94,094 | New Buy | 94,094 | $5.18 |
| Q2 2023 | -8,510 | Sold Out | 0 | $0.00 |
| Q1 2023 | +8,510 | New Buy | 8,510 | $9.93 |
| Q1 2021 | -858,270 | Sold Out | 0 | $0.00 |
| Q4 2020 | +216,352 | Add 33.70% | 858,270 | $6.86 |
| Q3 2020 | +641,918 | New Buy | 641,918 | $7.41 |
| Q3 2019 | -325,000 | Sold Out | 0 | $0.00 |
| Q2 2019 | +325,000 | New Buy | 325,000 | $6.00 |
Steven Cohen's Aldeyra Therapeutics Investment FAQs
Steven Cohen first purchased Aldeyra Therapeutics, Inc. (ALDX) in Q2 2019, acquiring 325,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Aldeyra Therapeutics, Inc. (ALDX) for 8 quarters since Q2 2019.
Steven Cohen's largest addition to Aldeyra Therapeutics, Inc. (ALDX) was in Q3 2020, adding 641,918 shares worth $4.76 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 94,094 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $487,407.
As of the Q4 2025 filing, Aldeyra Therapeutics, Inc. (ALDX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Aldeyra Therapeutics, Inc. (ALDX) was 858,270 shares, as reported at the end of Q4 2020.